Brent T Mausbach1,2, Gabrielle Decastro3,4, Richard B Schwab2,5, Maria Tiamson-Kassab1,2, Scott A Irwin6. 1. Department of Psychiatry, University of California San Diego, La Jolla, California. 2. Patient and Family Support Services, Moores Cancer Center, University of California San Diego, La Jolla, California. 3. Departments of Psychology, Ohio University, Athens, Ohio. 4. Department of Psychology, San Diego State University, San Diego, California. 5. Division of Hematology/Oncology, Department of Medicine, University of California San Diego, La Jolla, California. 6. Cedars-Sinai Cancer & Department of Psychiatry and Behavioral Neurosciences, Cedars Sinai Health System, Los Angeles, California.
Abstract
OBJECTIVE: Anxiety and depression are common in individuals with cancer and may impact healthcare service use and costs in this population. This study examined the effects of anxiety alone, depression alone, and comorbid anxiety and depressive disorder on healthcare use and costs among patients with cancer. METHOD: This was a retrospective cohort analysis of administrative data of patients aged 18 or older with an International Classification of Diseases, Ninth Revision diagnosis of cancer. Key outcomes were any visit to emergency department (ED), any inpatient hospitalization, length of hospital stays, and annual healthcare costs 1 year from cancer diagnosis. RESULTS: A total of 13,426 patients were included. Relative to patients with neither anxiety nor depression, those with anxiety alone, depression alone, or comorbid anxiety and depression were more likely to experience an ED visit and be hospitalized. Length of hospital stays were also longer and annual healthcare costs were significantly higher in all three clinical groups. CONCLUSIONS: Cancer patients with anxiety and depression were at greater risk for ED visits and hospitalizations, experienced longer hospital stays, and accrued higher healthcare costs. Future researchers should determine whether screening and treating comorbid anxiety and depression may decrease healthcare utilization and improve turnover wellbeing among cancer patients.
OBJECTIVE:Anxiety and depression are common in individuals with cancer and may impact healthcare service use and costs in this population. This study examined the effects of anxiety alone, depression alone, and comorbid anxiety and depressive disorder on healthcare use and costs among patients with cancer. METHOD: This was a retrospective cohort analysis of administrative data of patients aged 18 or older with an International Classification of Diseases, Ninth Revision diagnosis of cancer. Key outcomes were any visit to emergency department (ED), any inpatient hospitalization, length of hospital stays, and annual healthcare costs 1 year from cancer diagnosis. RESULTS: A total of 13,426 patients were included. Relative to patients with neither anxiety nor depression, those with anxiety alone, depression alone, or comorbid anxiety and depression were more likely to experience an ED visit and be hospitalized. Length of hospital stays were also longer and annual healthcare costs were significantly higher in all three clinical groups. CONCLUSIONS:Cancerpatients with anxiety and depression were at greater risk for ED visits and hospitalizations, experienced longer hospital stays, and accrued higher healthcare costs. Future researchers should determine whether screening and treating comorbid anxiety and depression may decrease healthcare utilization and improve turnover wellbeing among cancerpatients.
Authors: M P Luber; B S Meyers; P G Williams-Russo; J P Hollenberg; T N DiDomenico; M E Charlson; G S Alexopoulos Journal: Am J Geriatr Psychiatry Date: 2001 Impact factor: 4.105
Authors: Martin D Marciniak; Maureen J Lage; Eduardo Dunayevich; James M Russell; Lee Bowman; Ronald P Landbloom; Louise R Levine Journal: Depress Anxiety Date: 2005 Impact factor: 6.505
Authors: Francisco José Sánchez-Torralvo; Victoria Contreras-Bolívar; María Ruiz-Vico; José Abuín-Fernández; Inmaculada González-Almendros; Manuel Barrios; Gabriel Olveira Journal: Support Care Cancer Date: 2021-09-21 Impact factor: 3.359
Authors: Michael Kusch; Hildegard Labouvie; Vera Schiewer; Natalie Talalaev; Jan C Cwik; Sonja Bussmann; Lusine Vaganian; Alexander L Gerlach; Antje Dresen; Natalia Cecon; Sandra Salm; Theresia Krieger; Holger Pfaff; Clarissa Lemmen; Lisa Derendorf; Stephanie Stock; Christina Samel; Anna Hagemeier; Martin Hellmich; Bernd Leicher; Gregor Hültenschmidt; Jessica Swoboda; Peter Haas; Anna Arning; Andrea Göttel; Kathrin Schwickerath; Ullrich Graeven; Stefanie Houwaart; Hedy Kerek-Bodden; Steffen Krebs; Christiana Muth; Christina Hecker; Marcel Reiser; Cornelia Mauch; Jennifer Benner; Gerdamarie Schmidt; Christiane Karlowsky; Gisela Vimalanandan; Lukas Matyschik; Lars Galonska; Annette Francke; Karin Osborne; Ursula Nestle; Markus Bäumer; Kordula Schmitz; Jürgen Wolf; Michael Hallek Journal: BMC Health Serv Res Date: 2022-04-22 Impact factor: 2.908
Authors: Florie E van Beek; Femke Jansen; Rob J Baatenburg de Jong; Johannes A Langendijk; C René Leemans; Johannes H Smit; Robert P Takes; Chris H J Terhaard; José A E Custers; Judith B Prins; Birgit I Lissenberg-Witte; Irma M Verdonck-de Leeuw Journal: Curr Oncol Date: 2022-04-30 Impact factor: 3.109
Authors: Cassandra L Hua; Kali S Thomas; Lindsay J Peterson; Kathryn Hyer; David M Dosa Journal: J Am Med Dir Assoc Date: 2020-11-15 Impact factor: 4.669
Authors: Melissa Henry; Justine G Albert; Saul Frenkiel; Michael Hier; Anthony Zeitouni; Karen Kost; Alex Mlynarek; Martin Black; Christina MacDonald; Keith Richardson; Marco Mascarella; Gregoire B Morand; Gabrielle Chartier; Nader Sadeghi; Christopher Lo; Zeev Rosberger Journal: Front Psychol Date: 2022-03-24
Authors: Florie E Van Beek; Lonneke M A Wijnhoven; Karen Holtmaat; José A E Custers; Judith B Prins; Irma M Verdonck-de Leeuw; Femke Jansen Journal: Psychooncology Date: 2021-07-06 Impact factor: 3.955